Lagoda reports 14% stake in VolitionRX common stock
Lagoda Investment Management, L.P. filed an amended Schedule 13G reporting significant ownership in VolitionRX Ltd common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lagoda Investment Management, L.P. filed an amended Schedule 13G reporting significant ownership in VolitionRX Ltd common stock. As of June 30, 2026, accounts managed by Lagoda held 1,455,950 shares of common stock and warrants to purchase 171,055 shares at an exercise price of $0.60 per share. Based on 12,044,339 shares outstanding as of June 26, 2026, Lagoda is deemed to beneficially own 1,627,005 shares, representing 14.0% of VolitionRX’s common stock, with sole voting and dispositive power over these securities.
Key Figures
Key Terms
beneficially owns financial
Sole Voting Power financial
Sole Dispositive Power financial
warrants to purchase financial
Percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of VolitionRX Ltd (VNRX) does Lagoda Investment Management own?
What is the exercise price of Lagoda’s VolitionRX Ltd (VNRX) warrants?
Who controls voting and dispositive power over Lagoda’s VolitionRX Ltd (VNRX) holdings?
Who ultimately oversees Lagoda’s VolitionRX Ltd (VNRX) investment?
AI-generated analysis. How Rhea-AI works. Not financial advice.